When members of the marine mammal team from the International Fund for Animal Welfare rush to a Cape Cod beach to help a stranded dolphin or porpoise, they have no choice but to treat the endangered animal on site and then immediately release it.
That is about to change.
The organization, which protects animals worldwide, is opening a first-of-its-kind short-term dolphin hospital on Cape Cod this month that it hopes will not only improve survivability rates, but also enhance the research it has developed over 25 years.
Stranded marine mammals are stressed, in shock and dehydrated, said Brian Sharp, director of the rescue team. Simply caring for them at the scene is often not enough. They need additional diagnostics, treatment and recovery time.
“With this ICU for dolphins, we’ll be able to get them treatment that's needed, then be able to release them quickly,” he said.
While there are marine mammal rehabilitation centers that can take care of animals for months or even years, the goal of this facility is to release them back into the ocean within four days, he said.
“This is the first time that this has been attempted before," Sharp said.
There are more live marine mammal strandings on Cape Cod than anywhere else in the world, Sharp said. The welfare fund has responded to more than 400 live stranded dolphins, whales and porpoises in the region in the past five years alone, the organization said in a news release.
Cape Cod is a good habitat for dolphins, but a risky one. Its geography — it is basically a hook-shaped spit of sand jutting into the ocean — can make dolphin navigation difficult, and 12-foot tides can quickly expose a mile of beach.
The 4,200-square-foot (390-square-meter) Dolphin Rescue Center is in a renovated retail space in downtown Orleans.
It includes an 1,800-square-foot (167-square-meter) rehabilitation area with two treatment pools 15 feet (4.3 meters) across and a veterinary laboratory. The public will not be permitted to have direct contact with the animals being a cared for, but there is also an education center where visitors will be able to watch the recovering animals on a monitor.
Staffed by four full-time workers, it is equipped to provide round-the-clock care. It will start by treating one animal at a time, but the goal is to eventually treat multiple animals simultaneously.
The privately funded center has been federally inspected and expects to open by the end of the month, Sharp said.
“We want to take what we learn here and share it nationally, internationally,” he said.
Energy Vault, the company developing sustainable, grid-scale energy storage solutions, is now trading on the New York Stock Exchange following the completion of its business combination with Novus Capital Corporation II. Energy Vault develops sustainable, grid-scale energy storage solutions designed to advance the transition to a carbon free, resilient power grid. Robert Piconi, co-founder and CEO of Energy Vault, joins Cheddar News' Closing Bell to disucss.
In an effort to fight climate change several corporations have vowed to work to fight climate change by 2030. They say the goal is to reduce carbon emissions by 40% or even close to 100%. However, according to a new study, many of these companies are not actually practicing what they preach. Tom Egger, senior lecturer at Emeritus at the University of Wisconsin, joins Cheddar News to discuss more.
At-home medical labs company Getlabs raised $20 million in a Series A round, led by Emerson Collective and the Minderoo Foundation. Getlabs aims to be the boots-on-the-ground partner to telehealth. The company says more than 70% of medical decisions still require collecting diagnostic tests in person, and that it fills that void by delivering health care directly to their patients' homes. Founder & CEO of Getlabs Kyle Michelson joined Cheddar News' Closing Bell to discuss.
Kalle Marsal, Chief Operating Officer at PetDx, joins Cheddar Innovates to discuss how next-generation sequencing technology is being used to detect cancer in pets early.
On this episode of Cheddar Innovates: WALDO CEO breaks down why now is a good time to make eyecare a priority, and how they are democratizing access to eyecare for all; COO at PetDx explains how next-generation sequencing technology is being used to detect cancer in pets early; Cheddar gets a look at Curiosity Stream's 'Inside The Mind of a Con Artist.'
Shares of Canadian cannabis giant Canopy Growth surged after the company reported Q3 earnings Wednesday morning, with shares up more than 15 percent at the close of the day's trading session. Despite net revenue declining year-over-year, Canopy beat analyst expectations and has ramped up efforts to develop a "THC ecosystem' in the U.S. Canopy Growth's CEO, David Klein, joined Cheddar News' Closing Bell to discuss the report. He noted that its brands Storz & Bickel vaporizers and BioSteel beverages showed record growth.
The Central Park Conservancy announced last month it has partnered with the Yale School of the Environment and the New York City-based Natural Areas Conservancy to study the on-the-ground impacts of climate change on urban parks. Salmaan Khan, Director of Research and Special Projects at the Central Park Conservancy joins Cheddar Climate to explain what factors put this initiative into motion and what data his team will be looking to uncover.
Energy Impact Partners is a VC firm committed to helping the world move toward a more sustainable future. The tech-focused fund aims to reach $350 million for its Deep Decarbonization Frontier Fund,' which aims to support early-stage companies working on innovative solutions. Energy Impact Partners' Managing Director Andy Lubershane joined Cheddar Climate to discuss.
Mukul Bakhshi, Chief of Strategy and Government Affairs for CGFNS International, joins Cheddar News to discuss strained U.S. hospitals seeking foreign nurses.
The Democratic governors of New Jersey, Connecticut, Delaware, and Oregon say they will lift mask requirements for schools in the coming weeks, reflecting a nationwide shift away from restrictions. Cheddar News speaks with internist Dr. Vivek Cherian whether it's safe to relax the regulation.
